Back to search

Peptide record

TPDB09304

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
20 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB09304
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 20-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GLFTLIKGAYKNDAPTVACN
Physicochemical Analysis
C94H150N24O28S1
REQHMSW
A
2096.43
8.86
2
1
9
+1
0.62
0.180
88.00
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
1490
71.07
6
Residue Composition
number
3
A
0
R
2
N
1
D
1
C
0
E
0
Q
2
G
0
H
1
I
2
L
2
K
0
M
1
F
1
P
0
S
2
T
0
W
1
Y
1
V
Amino Acid Distribution
A: 3 R: 0 N: 2 D: 1 C: 1 E: 0 Q: 0 G: 2 H: 0 I: 1 L: 2 K: 2 M: 0 F: 1 P: 1 S: 0 T: 2 W: 0 Y: 1 V: 1
Chemical Descriptors
20
C94H150N24O28S1
2096.43
8.86
+1
0.62
0.180
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
24.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 2 Activity

Activity

MIC
Antibacterial
12.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
24.3 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
24.3 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 5 Activity

Activity

MIC
Antifungal
12.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
24.3 µM

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
24.3 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 8 Activity

Activity

MIC
Antiparasitic
12.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
24.3 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
24.3 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 11 Activity

Activity

MIC
Antiviral
12.2 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

ive against B. pyocyaneus (now P. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
24.3 µM

Target

Candida albicans

Source & Reference

DRAMP

Other

. aeruginosa) (MIC 48.6 ug/ml), E. coli (MIC 24.3 ug/ml), S. aureus (MIC 12.2 ug/ml), and C. albicans (MIC 24.3 uM). Updated 7/2021